-
Back to the 18’s. This drug may save millions of lives but it’s going to kill me!
$AMRN -
Hmm. Abandoned at USPTO. TODAY. Tidying up loose ends for the M&A?

h/t to cloak n dagger longs.
$AMRN pic.twitter.com/sNoMFwlYoM
-
Prikaži ovu nit
-
$AMRN insiders are buying shares. Quite a change... -
$AMRN has a bad technical rating, but it does show a decent setup pattern. https://www.chartmill.com/stock/analyzer/stock/AMRN?key=e4ea638c-11a8-4469-9e0a-515faaf5ddd2&utm_source=twitterUS&utm_medium=TA&utm_content=AMRN&utm_campaign=social_tracking …pic.twitter.com/szkXUFMKAP
-
-
-
$AMRN —But “Vascepa is just another fish oil.” But “Vascepa is a glorified aspirin.” But “The street blah blah blah.” Don’t I sound like a shiny object chasing#TWAT.#ClownMentalityhttps://twitter.com/drmarthagulati/status/1225029374375874560 …
-
Has a lot more than that coming to him.
$AMRN CEO Thero's Form 4: "As of the date of this Form 4, the Reporting Person owns or holds the right to acquire an aggregate of 9,673,730 Ordinary Shares" -
I’m convinced that Terra will know details of the BO before anyone else does......but in all seriousness good work again TErra,
$amrn time is coming soon -
-
$AMRN looks like a successful gap fill to me. Onward and upward. -
-
And dumped
$AMRN. -
Well, I can say I appreciate your professional approach though I disagree with your opinion. The share price is struggling right now but I’m in this long-term. Not trading. I see a bright future in
$AMRN and have done the appropriate due diligence to support my investment thesis. -
http://BlackboxStocks.US The World #1 Algorithm Based Alert Service for Traders! The REAL DEAL!!!
$ACB$GE$F$FIT$GPRO$CRON$HEXO$PLUG$ZNGA$CHK$NIO$GRPN$APHA$S$SIRI$AMZN$AAPL$TSLA$INTC$NVDA$AMD$AMRN$ACST$GGSM$XSPT$CNNA$IGPK$GBR$LEDS$DCTH$CBMX$RDCMpic.twitter.com/qcwxVFo22W
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

demonstrated icosapent ethyl (EPA) 30%
RRR & 2.6% absolute risk reduction in all-cause mortality.
